ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.500
-0.150 (-9.09%)
At close: Oct 17, 2025, 4:00 PM EDT
1.510
+0.010 (0.67%)
After-hours: Oct 17, 2025, 7:46 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $80.33 million as of October 17, 2025. Its market cap has decreased by -18.01% in one year.
Market Cap
80.33M
Enterprise Value
17.19M
1-Year Change
-18.01%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $80.33M, a decrease of -92.40%. That is a compound annual growth rate of -38.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 88.36M | 0.32% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |